From: Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines
Pathological parameters | Cases (n) | MAGE-1 | MAGE-3 | BAGE | GAGE-1/2 |
---|---|---|---|---|---|
Age | Â | Â | Â | Â | Â |
Pre-menopausal | 26 | 16 (61.5) | 9 (34.6) | 4 (15.4) | 7(26.9) |
Post-menopausal | 15 | 6 (40) | 6 (40) | 2 (13.3) | 4 (26.7) |
Histological grade | Â | Â | Â | Â | Â |
G1 ~G2 | 24 | 16 (66.7) | 12(50) | 3 (12.5) | 6(25) |
G3 | 17 | 6 (35.3) | 3(17.6) | 3(17.6) | 5 (29.4) |
Clinical stage | Â | Â | Â | Â | Â |
I ~II | 14 | 4(28.6) | 2 (14.3) | 2 (14.3) | 4 (28.6) |
III ~IV | 27 | 18 (66.7) | 13 (48.1) | 4 (14.8) | 7 (25.9) |
Lymph node metastasis | Â | Â | Â | Â | Â |
With | 15 | 10 (66.7) | 8 (53.3) | 3 (20) | 5 (33.3) |
Without | 26 | 12 (46.2) | 7 (26.9) | 3(11.5) | 6 (23.1) |
Ascites | Â | Â | Â | Â | Â |
With | 15 | 10 (66.7) | 8 (53.3) | 5 (33.3) | 7 (46.7) |
Without | 26 | 12 (46.2) | 7 (26.9) | 1 (3.8) | 4 (15.4) |